CLSI M24A

Susceptibility Testing of Mycobacteria, Nocardiae, and Other Aerobic Actinomycetes; Approved Standard, M24-A

Clinical and Laboratory Standards Institute, 04/01/2003

Publisher: CLSI

File Format: PDF

$135.00$271.99

Description

Published:01/04/2003

Pages:71

CLSI M24A provides protocols and related quality control parameters and interpretive criteria for the susceptibility testing of mycobacteria, Nocardiae spp. and other aerobic actinomycetes.

More CLSI standard pdf

CLSI EP18-A2 (R2018)

Risk Management Techniques to Identify and Control Laboratory Error Sources; Approved Guideline, Second Edition; EP18P3

$90.00 $180.00

CLSI POCT08-P

Quality Practices in Noninstrumented Near-Patient Testing: An Instructional Manual and Resources for Health Care Workers; Proposed Guideline, POCT08PE

$115.00 $231.48

CLSI I/LA31-A

Newborn Screening for Preterm, Low Birth Weight, and Sick Newborns; Approved Guideline, ILA31AE

$101.00 $203.14

CLSI GP34-P

Tubes and Additives for Venous and Capillary Blood Specimen Collection; Proposed Guideline, GP34PE

$104.00 $209.39